Veröffentlichungen & Konferenzbeiträge
Nikola Pluym, Therese Burkhardt, Till Weber, Max Scherer, Marike Kolossa-Gehring
ISES Europe Workshop 2026, Dublin, Ireland
Beyond cotinine: Implementing a comprehensive biomarker panel for nicotine product use monitoring in Europe
Nikola Pluym, Therese Burkhardt, Max Scherer
ISES Europe Workshop 2026, Dublin, Ireland
Nikola Pluym, Therese Burkhardt, Till Weber, Gerhard Scherer, Max Scherer, Marike Kolossa-Gehring
Journal of Exposure Science & Environmental Epidemiology
Amin Sajid, Nikola Pluym, Therese Burkhardt, Jonathan Belsey, Isaac John, Riccardo Polosa, Max Scherer
Journal of Environmental Exposure Assessment
Max Scherer, Riccardo Polosa, Simona Veigl, Nikola Pluym, Therese Burkhardt, Jonathan Belsey, Christopher Russell, Pascale Caponnetto, Jakub Weglarz, Davide Campagna
CORESTA PSPT 2025, Annecy, France
Nikola Pluym, Gerhard Scherer, Max Scherer
CORESTA PSPT 2025, Annecy, France
Max Scherer, Johanna Lehocky, Nikola Pluym
CORESTA PSPT 2025, Annecy, France
Carmen Tiwald, Veronika Spindler, Max Scherer, Nikola Pluym, Oliver Peschel, Edgar Leibold, Gerhard Scherer
ISBM 13, Milan, Italy
Veronika Spindler, Alpeshkumar Kachhadia, Nikola Pluym, Therese Burkhardt, Gerhard Scherer, Max Scherer
ISBM 13, Milan, Italy
Investigations on human biomonitoring for assessing the exposure to synthetic rose oxide in the general population
Carmen Tiwald, Veronika Spindler, Max Scherer, Nikola Pluym, Oliver Peschel, Edgar Leibold, Gerhard Scherer
Journal of Chromatography B
Wastewater-Based Epidemiology (WBE): Potential Application for Assessing the Use of Conventional and New Generation Tobacco and Nicotine Products
Gerhard Scherer, Nikola Pluym, Max Scherer
Contributions to Tobacco & Nicotine Research
Max Scherer, Gerhard Scherer, Kirsten Riedel, Holger M. Koch, Sonja A. Wrobel, Aline Murawski, Nora Lemke, Till Weber, Nikola Pluym, Marike Kolossa-Gehring
International Journal of Hygiene and Environmental Health
Oral health risks in adults who use electronic nicotine delivery systems and oral nicotine pouches: a critical review of the literature and qualitative synthesis of the available evidence
Gerhard Scherer, Nikola Pluym, Max Scherer
Harm Reduction Journal
External quality assurance schemes (EQUASs) and interlaboratory comparison investigations (ICIs) for the human biomonitoring of aromatic amines in urine as part of the quality assurance programme under HBM4EU
Stefanie Nübler, Therese Burkhardt, Moritz Schäfer, Johannes Müller, Karin Haji-Abbas-Zarrabi, Nikola Pluym, Max Scherer, Gerhard Scherer, Marta Esteban-Lopez, Argelia Castaño, Hans G. J. Mol, Holger M. Koch, Jean-Philippe Antignac, Jana Hajslova, Katrin Vorkamp, Thomas Göen
Analytical Methods
Nikola Pluym, Therese Burkhardt, Gerhard Scherer, Max Scherer, Till Weber, Marike Kolossa-Gehring
ISES Annual Meeting 2024, Montreal, Canada
Nikola Pluym, Janina Mütze, Kirsten Riedel, Gerhard Scherer, Therese Burkhardt, Max Scherer, Till Weber, Nora Lemke, Aline Murawski, Marike Kolossa-Gehring
ISES Annual Meeting 2024, Montreal, Canada
Nikola Pluym, Alpeshkumar Kachhadia, Therese Burkhardt, Gerhard Scherer, Max Scherer
ISES Annual Meeting 2024, Montreal, Canada
Nikola Pluym, Gerhard Scherer, Max Scherer
CORESTA Congress 2024, Edinburgh, UK
Identification of use-specific hemoglobin adduct patterns for different tobacco/nicotine product user groups by non-targeted GC-MS/MS analysis
Max Scherer, Fabian Pilz, Therese Burkhardt, Gerhard Scherer, Nikola Pluym
CORESTA Congress 2024, Edinburgh, UK
Max Scherer, Fabian Pilz, Antonia Gärtner, Gerhard Scherer, Nikola Pluym
CORESTA Congress 2024, Edinburgh, UK
Nikola Pluym, Richard Kanis, Therese Brukhardt, Gerhard Scherer, Max Scherer
CORESTA Congress 2024, Edinburgh, UK
Fabian Pilz, Therese Burkhardt, Gerhard Scherer, Max Scherer, Nikola Pluym
Chemical Research in Toxicology
Alpeshkumar Kachhadia, Therese Burkhardt, Gerhard Scherer, Max Scherer, Nikola Pluym
Journal of Chromatography B
A comprehensive non-targeted approach for the analysis of biomarkers in exhaled breath across different nicotine product categories
Therese Burkhardt, Filip Sibul, Fabian Pilz, Gerhard Scherer, Nikola Pluym, Max Scherer
Journal of Chromatography A
Nikola Pluym, Therese Burkhardt, Gerhard Scherer, Max Scherer
Harm Reduction Journal
Gerhard Scherer, Nikola Pluym, Max Scherer
Contributions to Tobacco & Nicotine Research
Protocol for the “magnitude of cigarette substitution after initiation of e-cigarettes and its impact on biomarkers of exposure and potential harm in dual users” (MAGNIFICAT) study
Riccardo Polosa, Nikola Pluym, Max Scherer, Jonathan Belsey, Chris Russell, Pasquale Caponnetto, Jakub Weglarz, Davide Campagna
Frontiers in Public Health
Development of a human biomonitoring method for assessing the exposure to 2,4,7,9-Tetramethyl-5-decyne-4,7-diol (TMDD) in the general population
Carmen Tiwald, Nadine Rögner, Gerhard Scherer, Nikola Pluym , Max Scherer
ISES Workshop 2024, Berlin, Germany
Identification of use specific hemoglobin adduct patterns for different tobacco/nicotine product user groups by non targeted GC-MS/MS analysis
Max Scherer, Fabian Pilz, Therese Burkhardt, Gerhard Scherer, Nikola Pluym
ISES Workshop 2024, Berlin, Germany
A sensitive GC–MS/MS method for the quantification of benzo[a]pyrene tetrol in urine
Fabian Pilz, Antonia Gärtner, Nikola Pluym, Gerhard Scherer, Max Scherer
Analytical and Bioanalytical Chemistry
Therese Burkhardt, Nikola Pluym, Gerhard Scherer, Filip Sibul, Max Scherer
CORESTA SSPT 2023, Cancun, Mexico
Revealing the urinary exposome of smokers, vapers, HTP users and pouch consumers by high-resolution LC-MS – an important step in the identification of use-specific biomarkers of exposure
Alpeshkumar Kachhadia, Nikola Pluym, Therese Burkhardt, Gerhard Scherer, Max Scherer
CORESTA SSPT 2023, Cancun, Mexico
Nikola Pluym, Richard Kanis, Kirsten Riedel, Therese Burkhardt, Gerhard Scherer, Max Scherer
CORESTA SSPT 2023, Cancun, Mexico
Comparison of biomarkers of exposure in users of various tobacco / nicotine products
Max Scherer, Therese Burkhardt, Gerhard Scherer, Nikola Pluym
CORESTA SSPT 2023, Cancun, Mexico
Human metabolism and excretion kinetics of the surfactant 2,4,7,9‑tetramethyl‑5‑decyne‑4,7‑diol (TMDD) after oral and dermal administration
Nikola Pluym, Nadine Roegner, Oliver Peschel, Edgar Leibold, Gerhard Scherer, Max Scherer
Monitoring the exposure to ethoxyquin between 2000 and 2021 in urine samples from the German Environmental Specimen Bank
Nikola Pluym, Therese Burkhardt, Nadine Rögner, Gerhard Scherer, Till Weber, Max Scherer, Marike Kolossa-Gehring
Environment International; doi: 10.1016/j.envint.2023.107781
Nadine Roegner, Nikola Pluym, Oliver Peschel, Edgar Leibold, Alpeshkumar Kachhadia, Gerhard Scherer, Max Scherer
Journal of Chromatography B; doi: 10.1016/j.jchromb.2022.123584
Gerhard Scherer, Kirsten Riedel, Nikola Pluym, Max Scherer
ACS Omega, doi: 10.1021/acsomega.2c06130
Time trend of exposure to secondhand tobacco smoke and polycyclic aromatic hydrocarbons between 1995 and 2019 in Germany – Showcases for successful European legislation
Therese Burkhardt, Max Scherer, Gerhard Scherer, Nikola Pluym, Till Weber, Marike Kolossa-Gehring
Environmental Research, doi: 10.1016/j.envres.2022.114638
Gerhard Scherer, Nikola Pluym, Max Scherer
Drug Testing and Analysis DOI: 10.1002/dta.3372
Propylene glycol as a specific biomarker for e-cigarette use Showcase of a novel Orbitrap-MS-based exposomics approach
Nikola Pluym, Therese Burkhardt, Alpesh Kachhadia, Gerhard Scherer, Max Scherer
ISES 2022, Lisbon
Therese Burkhardt, Max Scherer, Gerhard Scherer, Till Weber, Nikola Pluym, Marike Kolossa-Gehring
ISES 2022, Lisbon
Domenica Hahn, Maria Schmied-Tobies, Enrico Rucic, Nikola Pluym, Max Scherer, Malgorzata Debiak, Aline Murawski, Marike Kolossa-Gehring
Environmental Research doi.org/10.1016/j.envres.2022.114320
Gerhard Scherer, Max Scherer, Nadine Rögner, Nikola Pluym
Archives of Toxicology doi.org/10.1007/s00204-022-03349-4
Pluym N, Scherer G, Edmiston J, Jin X, Sarkar M, Scherer M
Chemical Research in Toxicology, doi:10.1021/acs.chemrestox.1c00431
Assessment of the Exposure to Tobacco-Specific Nitrosamines and Minor Tobacco Alkaloids in Users of Various Tobacco/Nicotine Products
Scherer G, Scherer M, Mütze J, Hauke T, Pluym N
Chemical Research in Toxicology, doi: 10.1021/acs.chemrestox.2c00020
Assessment of nicotine delivery and uptake in users of various tobacco / nicotine products
Scherer G, Mütze J, Pluym N, Scherer M
Current Research in Toxicology, Volume 3, 100067
Propylene glycol: A Biomarker of Exposure specific to E-Cigarette Consumption
Burkhardt T, Pluym N, Scherer G, Scherer M
SRNT 2022, Baltimore (Hybrid), USA
Time trend of the exposure to geraniol in 24-h urine samples derived from the German Environmental Specimen Bank from 2004 to 2018
Pluym N, Stoeckelhuber M, Weber T, Scherer G, Scherer M, Kolossa-Gehring M
International Journal of Hygiene and Environmental Health, Volume 239, doi.org/10.1016/j.ijheh.2021.113880
Intake and Uptake of Chemicals Upon Use of Various Tobacco/Nicotine Products: Can Users be Differentiated by Single or Combinations of Biomarkers?
Scherer G, Pluym N, Scherer M
Contributions to Tobacco & Nicotine Research, vol.30, no.4, 2021, pp.167-198
Analysis of 3-hydroxybenzo[a]pyrene in urine as a biomarker of exposure for benzo[a]pyrene in smokers and users of potentially reduced risk products
Scherer M, Rögner N, Scherer G, Pluym N
CORESTA SSPT 2021, Virtual
Quantitative analysis of NNN in plasma by LC-MS/MS: a suitable alternative to urinary determination to assess the exposure to this important toxicant
Pluym N, Sibul F, Jin X, Edmiston J, Sarkar M, Scherer G, Scherer M
CORESTA SSPT 2021, Virtual
1,2-Propylene Glycol: A Biomarker of Exposure Specific to e-Cigarette Consumption
Burkhardt T, Pluym N, Scherer G, Scherer M
Separations, 8, 180, doi: 10.3390/separations8100180
A Sensitive LC–MS/MS Method for the Quantification of 3-Hydroxybenzo[a]pyrene in Urine-Exposure Assessment in Smokers and Users of Potentially Reduced-Risk Products
Rögner N, Hagedorn H-W, Scherer G, Scherer M, Pluym N
Separations, 8(10), 171, doi: 10.3390/separations8100171
Assessment of the potential vaping-related exposure to carbonyls and epoxides using stable isotope-labeled precursors in the e-liquid
Landmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Niessner R, Pluym N
Archives of Toxicology, doi:10.1007/s00204-021-03097-x
Determination of propylene glycol and glycerol in plasma and urine: Exposure assessment in e-cigarette users compared to other nicotine product user groups
Burkhardt T, Scherer M, Scherer G, Pluym N
Global Forum on Nicotine 2021, Virtual
Analysis of 3-hydroxybenzo[a]pyrene in urine as a biomarker of exposure for benzo[a]pyrene in smokers and users of potentially reduced risk products
Rögner N, Scherer M, Scherer G, Pluym N
Global Forum on Nicotine 2021, Virtual
Identification of biomarkers specific to five different nicotine product user groups: Study protocol of a controlled clinical trial
Sibul F, Burkhardt T, Kachhadia A, Pilz F, Scherer G, Scherer M, Pluym N
Contemporary Clinical Trials Communications, Volume 22, doi: 10.1016/j.conctc.2021.100794
Quantitative analysis of NNN in plasma by LC-MS/MS: a suitable alternative to urinary determination to assess the exposure to this important toxicant
Pluym N, Jin X, Edmiston J, Sarkar M, Scherer G, Scherer M
SRNT 2021, Virtual
Human biomonitoring in urine samples from the Environmental Specimen Bank reveals a decreasing trend over time in the exposure to the fragrance chemical lysmeral from 2000 to 2018
Scherer M, Petreanu W, Weber T, Scherer G, Pluym N, Kolossa-Gehring M
Chemosphere, Volume 265, doi: 10.1016/j.chemosphere.2020.128955
Benzene metabolite SPMA and acrylamide metabolites AAMA and GAMA in urine of children and adolescents in Germany - human biomonitoring results of the German Environmental Survey 2014-2017 (GerES V)
Schwedler G, Murawski A, Schmied-Tobies MIH, Rucic E, Scherer M, Pluym N, Scherer G, Bethke R, Kolossa-Gehring M
Environmental Research, Volume 192, doi: 10.1016/j.envres.2020.110295
Analysis of chemical deposits on tooth enamel exposed to total particulate matter from cigarette smoke and tobacco heating system 2.2 aerosol by novel GC-MS deconvolution procedures
Haiduc A, Zanetti F, Zhao X, Schlage WK, Scherer M, Pluym N, Schlenger P, Ivanov NV, Majeed S, Hoeng J, Peitsch MC, Ren Y, Guy PA
Journal of Chromatography B, Volume 1152, doi: 10.1016/j.jchromb.2020.122228
A novel quantification method for sulfur-containing biomarkers of formaldehyde and acetaldehyde exposure in human urine and plasma samples
Landmesser A, Scherer G, Pluym N, Niessner R, Scherer M
Analytical and Bioanalytical Chemistry, volume 412, doi: 10.1007/s00216-020-02888-y
Development of a human biomonitoring method for assessing the exposure to ethoxyquin in the general population
Stoeckelhuber M, Scherer M, Bracher F, Peschel O, Leibold E, Scherer G, Pluym N
Archives of Toxicology, volume 94, doi: 10.1007/s00204-020-02871-7
Metabolites of the fragrance 2-(4-tert-butylbenzyl)propionaldehyde (lysmeral) in urine of children and adolescents in Germany - Human biomonitoring results of the German Environmental Survey 2014-2017 (GerES V)
Murawski A, Fiedler N, Schmied-Tobies MIH, Rucic E, Schwedler G, Stoeckelhuber M, Scherer G, Pluym N, Scherer M, Kolossa-Gehring M
International Journal of Hygiene and Environmental Health, Volume 229, 10.1016/j.ijheh.2020.113594
Human metabolism and urinary excretion kinetics of the UV filter Uvinul A plus® after a single oral or dermal dosage
Stoeckelhuber M, Scherer M, Peschel O, Leibold E, Bracher F, Scherer G, Pluym N
International Journal of Hygiene and Environmental Health, 227:113509, doi: 10.1016/j.ijheh.2020.113509
Biomonitoring data on young adults from the Environmental Specimen Bank suggest a decrease in the exposure to the fragrance chemical 7-hydroxycitronellal in Germany from 2000 to 2018
Pluym N, Petreanu W, Weber T, Scherer G, Scherer M, Kolossa-Gehring M
International Journal of Hygiene and Environmental Health, 227:113508, doi: 10.1016/j.ijheh.2020.113508
Polycyclic aromatic hydrocarbons (PAH) in urine of children and adolescents in Germany - human biomonitoring results of the German Environmental Survey 2014-2017 (GerES V)
Murawski A, Roth A, Schwedler G, Schmied-Tobies MIH, Rucic E, Pluym N, Scherer M, Scherer G, Conrad A, Kolossa-Gehring M
International Journal of Hygiene and Environmental Health, Volume 226, doi: 10.1016/j.ijheh.2020.113491
A validated UPLC-MS/MS method for the determination of urinary metabolites of Uvinul® A plus
Stoeckelhuber M, Pluym N, Bracher F, Leibold E, Scherer G, Scherer M
Analytical and Bioanalytical Chemistry, volume 411, doi: 10.1007/s00216-019-02201-6
Analysis of aldehydes, propylene oxide and glycidol in tobacco smoke and e-cigarette vapor and their respective urinary biomarkers
Landmesser A, Scherer G, Pluym N, Scherer M
CORESTA SSPT 2019, Hamburg, Germany
Clinical biomarkers of compliance for use in potentially reduced-risk product switching studies
McEwan M, Gale N, Hardie G, Scherer M, Pluym N, Ebajemito JK, Camacho OM, Griffiths A, Proctor CJ
CORESTA SSPT 2019, Hamburg, Germany
NNN a suitable biomarker of exposure from smoke and new nicotine delivery products?
Pluym N, Taucher J, Scherer G, Scherer M
CORESTA SSPT 2019, Hamburg, Germany
Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled Ingredients
Landmesser A, Scherer M, Pluym N, Sarkar M, Edmiston J, Niessner R, Scherer G
Nicotine & Tobacco Research, Volume 21, doi: 10.1093/ntr/nty204
Novel biomarkers to characterize the specific exposure to aldehydes or epoxides from e-vapor products based on stable-isotope labeled constituents
Landmesser A, Scherer M, Scherer G, Pluym N
SRNT 2019, San Francisco, USA
Analytical methods for the determination of carbonyls in aerosol from e-vapor products and cigarette smoke and their urinary biomarkers of exposure
Landmesser A, Scherer M, Scherer G, Pluym N
CORESTA Congress 2018, Kunming, China
Identifying suitable biomarkers of biological effects (BOBEs) for evaluating reduced risk products
Scherer G, Pluym N, Scherer M
CORESTA Congress 2018, Biomarker Workshop, Kunming, China
Novel biomarkers to characterize exposure to aldehydes from e-vapor products based on stable-isotope constituents
Landmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N
CORESTA Congress 2018, Kunming, China
Collaborative Method Performance Study of the Measurement of Nicotine, Its Metabolites, and Total Nicotine Equivalents in Human Urine
Wang L, Bernert JT, Benowitz NL, Feng J, Jacob P 3rd, McGahee E, Caudill SP, Scherer G, Scherer M, Pluym N, Doig MV, Newland K, Murphy SE, Caron NJ, Sander LC, Shimizu M, Yamazaki H, Kim S, Langman LJ, Pritchett JS, Sniegoski LT, Li Y, Blount BC, Pirkle JL
Cancer Epidemiology, Biomarkers & Prevention, Volume 27, doi: 10.1158/1055-9965
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature review
Scherer G
Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002
Analysis of Urinary Eicosanoids by LC-MS/MS Reveals Alterations in the Metabolic Profile after Smoking Cessation
Goettel M, Niessner R, Scherer M, Scherer G, Pluym N
Chemical Research in Toxicology, Volume 31, doi: 10.1021/acs.chemrestox
Biomarkers of exposure specific to e-vapor products based on stable-isotope labeled ingredients
Landmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N
SRNT 2018, Baltimore, USA
Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products
Peck MJ, Sanders EB, Scherer G, Luedicke F, Weitkunat R
Biomarkers, Volume 23(3), doi: 10.1080/1354750X.2017.1419284
Human metabolism and excretion kinetics of the fragrance 7-hydroxycitronellal after a single oral or dermal dosage
Stoeckelhuber M, Krnac D, Pluym N, Scherer M, Peschel O, Leibold E, Scherer G
International Journal of Hygiene and Environmental Health, Volume 221, doi: 10.1016/j.ijheh.2017.10.015
A validated UPLC-MS/MS method for biomonitoring the exposure to the fragrance 7-hydroxycitronellal
Stoeckelhuber M, Krnac D, Pluym N, Scherer M, Leibold E, Scherer G
Journal of Chromatography B, Volumes 1068–1069, doi: doi.org/10.1016/j.jchromb.2017.10.040
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methods
Landmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M
CORESTA SSPT 2017, Kitzbühel, Austria
Metabolomic Fingerprinting in Various Body Fluids of a Diet-Controlled Clinical Smoking Cessation Study Using a Validated GC-TOF-MS Metabolomics Platform
Goettel M, Niessner R, Mueller D, Scherer M, Scherer G, Pluym N
Journal of Proteome Research, Volume 16(10), doi: 10.1021/acs.jproteome.7b00128.
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–results
Landmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N
CORESTA SSPT 2017, Kitzbühel, Austria
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–study design
Landmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M
CORESTA SSPT 2017, Kitzbühel, Austria
A fully validated GC-TOF-MS method for the quantification of fatty acids revealed alterations in the metabolic profile of fatty acids after smoking cessation
Goettel M, Niessner R, Pluym N, Scherer G, Scherer M
Journal of Chromatography B, Volumes 1041–1042, doi: 10.1016/j.jchromb.2016.12.035
Analysis of the ‘butter-type‘ flavor compounds diacetyl, acetoin, and 2,3-pentanedione in e-cigarette liquids
Riedel K, Scherer G, Scherer M, Pluym N
CORESTA Congress 2016, Berlin, Germany
Impact of smoking cessation on the metabolic profile of former smokers
Goettel M, Mueller DC, Pluym N, Scherer G, Scherer M
CORESTA Congress 2016, Berlin, Germany
Ultra-sensitive method for the determination of nicotine in PK studies with next generation products
Wanderer F, Pluym N, Scherer G, Scherer M
CORESTA Congress 2016, Berlin, Germany
Human metabolism and excretion kinetics of the fragrance lysmeral after a single oral dosage
Scherer M, Koch HM, Schütze A, Pluym N, Krnac D, Gilch G, Leibold E, Scherer G
International Journal of Hygiene and Environmental Health, Volume 220, doi: 10.1016/j.ijheh.2016.09.005
Pluym N, Krnac D, Gilch G, Scherer M, Leibold E, Scherer G
Analytical and Bioanalytical Chemistry, Volume 408, doi: 10.1007/s00216-016-9702-x
Determination of flavors and their metabolites in e-liquids and biological fluids - Identification of biomarkers of exposure to prominent e-cigarette flavors
Riedel K, Pluym N, Scherer G, Scherer M
CORESTA SSPT 2015, Jeju, South Korea
Impact of smoking cessation on the metabolic profile of former smokers
Goettel M, Mueller DC, Pluym N, Scherer G, Scherer M
CORESTA SSPT 2015, Jeju, South Korea
Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methods
Pluym N, Gilch G, Scherer G, Scherer M
Analytical and Bioanalytical Chemistry, Volume 407, doi: 10.1007/s00216-015-8719-x
Analysis of 18 Urinary Mercapturic Acids by two Multiplex-LC-MS/MS Methods
Pluym N, Gilch G, Scherer G, Scherer M
CORESTA Congress 2014, Quebec, Canada
Smoking behaviour and compensation: a review of the literature with meta-analysis
Scherer G, Lee PN
Regulatory Toxicology and Pharmacology, Volume 70, doi: 10.1016/j.yrtph.2014.09.008
A correlation study applied to biomarkers of internal and effective dose for acrylonitrile and 4-aminobiphenyl in smokers
Scherer G, Newland K, Papadopoulou E, Minet E
Biomarkers, Volume 19(4), doi: 10.3109/1354750X.2014.910271
Saliva as a matrix for human biomonitoring in occupational and environmental medicine
Michalke B, Rossbach B, Göen T, Schäferhenrich A, Scherer G
International Archives of Occupational and Environmental Health, volume 88, doi: 10.1007/s00420-014-0938-5
Metabolomics using GC-TOF-MS followed by subsequent GC-FID and HILIC-MS/MS analysis revealed significantly altered fatty acid and phospholipid species profiles in plasma of smokers
Mueller DC, Degen C, Scherer G, Jahreis G, Niessner R, Scherer M
Journal of Chromatography B, Volume 966, doi: 10.1016/j.jchromb.2014.02.044
Untargeted metabolomic profiling in saliva of smokers and nonsmokers by a validated GC-TOF-MS method
Mueller DC, Piller M, Niessner R, Scherer M, Scherer G
Journal of Proteome Research, Volume 13, doi: 10.1021/pr401099r
Simple, fast and sensitive LC-MS/MS analysis for the simultaneous quantification of nicotine and 10 of its major metabolites
Piller M, Gilch G, Scherer G, Scherer M
Journal of Chromatography B, Volumes 951–952, doi: 10.1016/j.jchromb.2014.01.025
Untargeted metabolomic profiling in saliva of smokers and non-smokers by a validated GC-TOF-MS method
Scherer M, Mueller DC, Pluym N, Scherer G
CORESTA Congress 2014, Quebec, Canada
Assessing the exposure to ‘smoke’ from electronic cigarettes by biomarkers
Scherer G, Hagedorn H-W, Riedel K, Scherer M
CORESTA SSPT 2013, Seville, Spain
Methodology and application of a non-targeted metabolome platform for biological samples of smokers and nonsmokers
Mueller DC, Scherer M, Degen C, Scherer G
CORESTA SSPT 2013, Seville, Spain
A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoids
Sterz K, Scherer G, Ecker J
Journal of Lipid Research, Volume 53, doi: 10.1194/jlr.D023739
A liquid chromatography/tandem mass spectrometry (LC-MS/MS) method for the determination of phenolic polycyclic aromatic hydrocarbons (OH-PAH) in urine of non-smokers and smokers
Ramsauer B, Sterz K, Hagedorn H-W, Engl J, Scherer G, McEwan M, Errington G, Shepperd J, Cheung F
Analytical and Bioanalytical Chemistry, volume 399, doi:10.1007/s00216-010-4355-7
Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers
Kavvadias D, Scherer G, Cheung F, Errington G, Shepperd J, McEwan M
Biomarkers, Volume 14, doi: 10.3109/13547500903242883
Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urine
Kavvadias D, Scherer G, Urban M, Cheung F, Errington G, Shepperd J, McEwan M
Journal of Chromatography B, Volume 877, doi: 10.1016/j.jchromb.2009.03.009
Riedel K, Scherer G, Engl J, Hagedorn H-W, Tricker AR
Journal of Analytical Toxicology, Volume 30, doi: 10.1093/jat/30.3.187
Urinary Mercapturic Acids and a Hemoglobin Adduct for the Dosimetry of Acrylamide Exposure in Smokers and Nonsmokers
Urban M, Kavvadias D, Riedel K, Scherer G, Tricker AR
Inhalation Toxicology, Volume 18, doi: 10.1080/08958370600748430
Haben Sie Fragen zu unserer Forschung? Kontaktieren Sie uns!